---
created: 2025-04-13
updated: 2025-04-13T10:53
id: Q1-0|xPg6I
specialty: pharmaco
specialty_id: 559
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::04-therapeutic-antibodies::benralizumab
  - "source/ak-step1-v11:": 
  - theme/firstaid::16-respiratory::05-pharm::07-asthma-drugs
  - "source/ak-step1-v11:": 
  - theme/firstaid::16-respiratory::05-pharm::07-asthma-drugs::anti-il5-monoclonal-therapy
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::08-respiratory::08-anti-il-5-monoclonal-therapy
  - source/ak-step1-v11::$ankingadds::fa2020::respiratory
  - source/ak-step1-v11::^other::^highyield::4-loweryield
  - source/ak-step1-v11::^systems::respiratory::akadds"
type: flashcard
---

# Question
**Benralizumab** is a monoclonal antibody against **IL-5 receptor alpha** used for maintenance therapy of asthma

---

# Answer
